SecBot SecBot
Insider Cluster (3 insiders) ·Filed Sep 9, 2026

RLAY

Relay Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

The CEO and President of R&D selling on the same day is a modest caution flag against the overwhelmingly bullish analyst consensus. Monitor for any upcoming clinical data readouts or pipeline updates that could explain the timing. The dollar amount is too small to be a strong bearish signal, but the cluster nature and seniority of sellers warrant watching the next 8-K or press release for context.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$18.89
T+0 close · Sep 9, 2026 · via day close
Latest settled
−7.83%
T+20 · $17.41 · next T+60 in 17d
Vs SPY
−10.21%
α at T+20
Latest observation
+5.78%
T+46 · FF3 residual α
  1. T+0 · Sep 10 $18.89entry
  2. T+1 · 2mo ago −0.11%α −0.96% · $18.87
  3. T+5 · 2mo ago +1.59%α +0.96% · $19.19
  4. T+20 · 6w ago −7.83%α −10.21% · $17.41
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two top executives at Relay Therapeutics, CEO Sanjiv Patel and President of R&D Donald Bergstrom, sold a combined $1.07M in open-market sales on September 8, 2026. While the dollar amount is modest relative to the $4.2B market cap (~0.03%), the cluster involves the CEO and President of R&D selling on the same day, which warrants attention. The stock has a 95% analyst buy rating and strong institutional support, but the insider sales introduce a note of caution against the bullish consensus.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
3

Key Facts

  • CEO Sanjiv Patel sold 48,199 shares at $18.94 for $912,889 on September 8, 2026.
  • President of R&D Donald Bergstrom sold 8,530 shares at $18.97 for $161,814 on September 8, 2026.
  • CFO Thomas Catinazzo also sold 17,717 shares at $18.94 for $335,560 on September 8, 2026.
  • Total cluster value is $1.07M, representing approximately 0.03% of the $4.2B market cap.
  • The stock has 95% analyst buy rating (19 Buy/Strong Buy, 1 Hold, 0 Sell).
  • Institutional 13F shows strong accumulation: 11 adds, 6 doubled positions, only 2 trims.

Financial Impact

Insider sales of $1.07M represent 0.03% of market cap, trivial in absolute size but notable for involving the CEO and President of R&D on the same day.

insider ownership

Risk Factors

  • Insider sales by CEO and President of R&D could signal reduced conviction ahead of upcoming pipeline milestones.
  • The stock's high valuation (95% analyst buy rating) leaves limited upside if clinical data disappoints.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RLAY-1789030928152

Track record

21 reports on RLAY

Performance horizon

6 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +65.12% at T+60 after the May 19, 2026 report. 8 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G Neutral 4/10 Entry $17.68 Now $17.27 −2.29% settles Feb 12
  3. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  4. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $17.00 Now $17.27 +1.59% settles Feb 3
  5. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $17.44 Now $17.27 −0.97% settles Feb 1
  6. Oct 7, 20265w ago 144 Neutral 2/10 Entry $17.41 Now $17.27 −0.80% settles Jan 5
  7. Oct 6, 20265w ago 144 Neutral 3/10 Entry $17.95 Now $17.27 −3.79% settles Jan 4
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Viewing Entry $18.89 Now $17.27 −8.58% settles Dec 4
  9. Aug 28, 202611w ago Insider Cluster Bearish 6/10 Entry $18.77 Now $17.27 +7.99% settles Nov 23
  10. Aug 18, 202612w ago Insider Cluster Bearish 5/10 Entry $20.74 to $19.72 Now $17.27 +16.73% ▲ +4.92% +4.09% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Wed (9h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 10, 2026